ABCB1 and cancer: The in vivo studies further confirmed the reversal effect of lapatinib on ABCB1-mediated MDR, therefore indicated that combination of lapatinib with other anticancer drugs may be important in surmounting clinical resistance in cancer chemotherapy [56].